APC and colon carcinoma: Moreover, the pyrvinium treatment of colon carcinoma cells (HCT116 and SW480) with mutated adenomatous polyposis coli (APC) or β-catenin (CTNNB1) suppressed cell proliferation via inhibiting Wnt signalling [94].